Search

Search Constraints

You searched for: Author/Creator Yokota, Kenji

Search Results

1. A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanoma. Issue 8 (30th June 2022)

2. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

3. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

4. Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study. Issue 12 (22nd October 2019)

5. Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study). Issue 44 (30th October 2020)

7. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system. Issue 2 (May 2019)

8. Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma. (1st April 2019)

9. Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node. (19th October 2013)

10. Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node. (19th October 2013)